In 40 seconds
Up to 85% of people with Parkinson's report pain — musculoskeletal (rigid muscles, postural changes), dystonic, central neuropathic, or related. Pain in PD is often under-treated. PEMF therapy reduces inflammation, supports muscle recovery, and may modulate central pain processing — used widely as adjunct in PD pain management.
Quick facts
- Affected: Up to 85% of people with PD report pain
- Pain types: Musculoskeletal, dystonic, central neuropathic
- PEMF role: Inflammation, muscle recovery, central modulation
- Sessions: 2-3× per week × 8 weeks then maintenance
How PEMF may help
Rigidity-related muscle pain comes from sustained tone. Postural changes load joints abnormally. Central pain reflects altered pain processing in basal ganglia circuits. PEMF can address each layer.
Practical use
Localised PEMF over painful areas (lower back, shoulders, hips most common) plus full-body mat for systemic effect. 2-3 sessions per week initially.
Contraindications
Standard PEMF contraindications: pacemakers, defibrillators, cochlear implants, insulin pumps, electronic implants; active malignancy without specialist clearance; pregnancy (over the abdomen); active infection; epilepsy without GP clearance.
Frequently asked questions
Why does Parkinson's cause pain?
Multiple mechanisms — rigidity, postural change, dystonia, altered central pain processing. Multimodal treatment is key.
Will it reduce my opioid use?
Many patients reduce opioid dose under medical guidance once PEMF effect builds.
Looking for a PEMF clinic near you?
We list every credible PEMF therapy provider in the UK so you can find one near home.